O’Melveny & Myers has advised Cofoe Medical Technology Co., Ltd. on its Hong Kong Stock Exchange listing. Cofoe Medical Technology Co., Ltd. has completed its listing...
Cofoe Medical Completes HK$1.062 Billion Listing on the Hong Kong Stock Exchange
Tiantu Capital Sells Yoplait China Stake for RMB1.8 Billion
O’Melveny & Myers has advised Tian Tu Capital Co., Ltd. on the sale of its interest in Yoplait Dairy Co., Ltd. and on related Hong Kong...
TransThera Sciences Completes HK$190 Million Placement of New H Shares
O’Melveny & Myers has advised TransThera Sciences (Nanjing), Inc. TransThera Sciences (Nanjing), Inc. has completed the placement of 2,100,000 new H shares under a general mandate,...
Ribo Life Science Completes HK$1.83 Billion Hong Kong IPO
Kirkland & Ellis has advised Suzhou Ribo Life Science Co., Ltd. on its global offering and listing. O’Melveny & Myers has represented the joint sponsors CICC...
Forest Cabin Completes Hong Kong IPO and Main Board Listing
Clifford Chance has advised Shanghai Forest Cabin Cosmetics Group Co., Ltd. (Forest Cabin). O’Melveny has represented joint sponsors and other underwriters. Shanghai Forest Cabin Cosmetics Group...
CNGR Advanced Material Completes US$450 Million A+H Share Listing on Hong Kong Stock Exchange
O’Melveny has advised the joint sponsors and underwriters. CNGR Advanced Material Co., Ltd. has completed its A+H share listing on the Main Board of the Hong...
Vigonvita Life Sciences Completes HK$600 Million IPO on Hong Kong Stock Exchange
O’Melveny has advised Vigonvita Life Sciences Co., Ltd. Vigonvita Life Sciences Co., Ltd. has completed its initial public offering and listing on the Main Board of...